Global Rituximab Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1964525
- Published On: Aug, 2020
- Category : Pharmaceuticals
- Pages : 112
-
Rituximab is a human-mouse chimeric monoclonal antibody that acts on human CD20. Since CD20 is mainly expressed on the surface of B lymphocytes, molybdenum can be used to treat diseases caused by excessive B lymphocytes, including lymphoma, leukemia, transplant rejection and certain autoimmune diseases.
The Rituximab market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Rituximab industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Rituximab market can be split based on product types, major applications, and important countries as follows:
Key players in the global Rituximab market covered in Chapter 12:
Chugai
Genentech, Inc
Zenyaku Kogyo
Biogen
Roche
In Chapter 4 and 14.1, on the basis of types, the Rituximab market from 2015 to 2025 is primarily split into:
Solution
Injection
In Chapter 5 and 14.2, on the basis of applications, the Rituximab market from 2015 to 2025 covers:
non-Hodgkin's lymphoma (NHL)
chronic lymphocytic leukaemia (CLL)
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Rituximab market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Rituximab Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Rituximab
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Rituximab industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Rituximab Market Size, 2015 – 2020
2.1.2 Global Rituximab Market Size by Type, 2015 – 2020
2.1.3 Global Rituximab Market Size by Application, 2015 – 2020
2.1.4 Global Rituximab Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Rituximab Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Rituximab Analysis
3.2 Major Players of Rituximab
3.3 Rituximab Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Rituximab
3.3.3 Labor Cost of Rituximab3.4 Market Distributors of Rituximab
3.5 Major Downstream Buyers of Rituximab Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Rituximab Market, by Type4.1 Global Rituximab Value and Market Share by Type (2015-2020)
4.2 Global Rituximab Production and Market Share by Type (2015-2020)
4.3 Global Rituximab Value and Growth Rate by Type (2015-2020)
4.3.1 Global Rituximab Value and Growth Rate of Solution
4.3.2 Global Rituximab Value and Growth Rate of Injection4.4 Global Rituximab Price Analysis by Type (2015-2020)
5 Rituximab Market, by Application5.1 Downstream Market Overview
5.2 Global Rituximab Consumption and Market Share by Application (2015-2020)
5.3 Global Rituximab Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Rituximab Consumption and Growth Rate of non-Hodgkin's lymphoma (NHL) (2015-2020)
5.3.2 Global Rituximab Consumption and Growth Rate of chronic lymphocytic leukaemia (CLL) (2015-2020)
5.3.3 Global Rituximab Consumption and Growth Rate of Others (2015-2020)
6 Global Rituximab Market Analysis by Regions6.1 Global Rituximab Sales, Revenue and Market Share by Regions
6.1.1 Global Rituximab Sales by Regions (2015-2020)
6.1.2 Global Rituximab Revenue by Regions (2015-2020)6.2 North America Rituximab Sales and Growth Rate (2015-2020)
6.3 Europe Rituximab Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Rituximab Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Rituximab Sales and Growth Rate (2015-2020)
6.6 South America Rituximab Sales and Growth Rate (2015-2020)
7 North America Rituximab Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Rituximab Sales, Revenue and Market Share by Countries
7.2.1 North America Rituximab Sales by Countries (2015-2020)
7.2.2 North America Rituximab Revenue by Countries (2015-2020)7.3 United States Rituximab Sales and Growth Rate (2015-2020)
7.4 Canada Rituximab Sales and Growth Rate (2015-2020)
7.5 Mexico Rituximab Sales and Growth Rate (2015-2020)
8 Europe Rituximab Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Rituximab Sales, Revenue and Market Share by Countries
8.2.1 Europe Rituximab Sales by Countries (2015-2020)
8.2.2 Europe Rituximab Revenue by Countries (2015-2020)8.3 Germany Rituximab Sales and Growth Rate (2015-2020)
8.4 UK Rituximab Sales and Growth Rate (2015-2020)
8.5 France Rituximab Sales and Growth Rate (2015-2020)
8.6 Italy Rituximab Sales and Growth Rate (2015-2020)
8.7 Spain Rituximab Sales and Growth Rate (2015-2020)
8.8 Russia Rituximab Sales and Growth Rate (2015-2020)
9 Asia Pacific Rituximab Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Rituximab Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Rituximab Sales by Countries (2015-2020)
9.2.2 Asia Pacific Rituximab Revenue by Countries (2015-2020)9.3 China Rituximab Sales and Growth Rate (2015-2020)
9.4 Japan Rituximab Sales and Growth Rate (2015-2020)
9.5 South Korea Rituximab Sales and Growth Rate (2015-2020)
9.6 India Rituximab Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Rituximab Sales and Growth Rate (2015-2020)
9.8 Australia Rituximab Sales and Growth Rate (2015-2020)
10 Middle East and Africa Rituximab Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Rituximab Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Rituximab Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Rituximab Revenue by Countries (2015-2020)10.3 Saudi Arabia Rituximab Sales and Growth Rate (2015-2020)
10.4 UAE Rituximab Sales and Growth Rate (2015-2020)
10.5 Egypt Rituximab Sales and Growth Rate (2015-2020)
10.6 Nigeria Rituximab Sales and Growth Rate (2015-2020)
10.7 South Africa Rituximab Sales and Growth Rate (2015-2020)
11 South America Rituximab Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Rituximab Sales, Revenue and Market Share by Countries
11.2.1 South America Rituximab Sales by Countries (2015-2020)
11.2.2 South America Rituximab Revenue by Countries (2015-2020)11.3 Brazil Rituximab Sales and Growth Rate (2015-2020)
11.4 Argentina Rituximab Sales and Growth Rate (2015-2020)
11.5 Columbia Rituximab Sales and Growth Rate (2015-2020)
11.6 Chile Rituximab Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Chugai
12.1.1 Chugai Basic Information
12.1.2 Rituximab Product Introduction
12.1.3 Chugai Production, Value, Price, Gross Margin 2015-202012.2 Genentech, Inc
12.2.1 Genentech, Inc Basic Information
12.2.2 Rituximab Product Introduction
12.2.3 Genentech, Inc Production, Value, Price, Gross Margin 2015-202012.3 Zenyaku Kogyo
12.3.1 Zenyaku Kogyo Basic Information
12.3.2 Rituximab Product Introduction
12.3.3 Zenyaku Kogyo Production, Value, Price, Gross Margin 2015-202012.4 Biogen
12.4.1 Biogen Basic Information
12.4.2 Rituximab Product Introduction
12.4.3 Biogen Production, Value, Price, Gross Margin 2015-202012.5 Roche
12.5.1 Roche Basic Information
12.5.2 Rituximab Product Introduction
12.5.3 Roche Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Rituximab Market Forecast14.1 Global Rituximab Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Solution Market Value and Volume Forecast (2020-2025)
14.1.2 Injection Market Value and Volume Forecast (2020-2025)14.2 Global Rituximab Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 non-Hodgkin's lymphoma (NHL) Market Value and Volume Forecast (2020-2025)
14.2.2 chronic lymphocytic leukaemia (CLL) Market Value and Volume Forecast (2020-2025)
14.2.3 Others Market Value and Volume Forecast (2020-2025)14.3 Rituximab Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Rituximab
Table Product Specification of Rituximab
Table Rituximab Key Market Segments
Table Key Players Rituximab Covered
Figure Global Rituximab Market Size, 2015 – 2025
Table Different Types of Rituximab
Figure Global Rituximab Value ($) Segment by Type from 2015-2020
Figure Global Rituximab Market Share by Types in 2019
Table Different Applications of Rituximab
Figure Global Rituximab Value ($) Segment by Applications from 2015-2020
Figure Global Rituximab Market Share by Applications in 2019
Figure Global Rituximab Market Share by Regions in 2019
Figure North America Rituximab Production Value ($) and Growth Rate (2015-2020)
Figure Europe Rituximab Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Rituximab Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Rituximab Production Value ($) and Growth Rate (2015-2020)
Figure South America Rituximab Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Rituximab
Table Upstream Raw Material Suppliers of Rituximab with Contact Information
Table Major Players Headquarters, and Service Area of Rituximab
Figure Major Players Production Value Market Share of Rituximab in 2019
Table Major Players Rituximab Product Types in 2019
Figure Production Process of Rituximab
Figure Manufacturing Cost Structure of Rituximab
Figure Channel Status of Rituximab
Table Major Distributors of Rituximab with Contact Information
Table Major Downstream Buyers of Rituximab with Contact Information
Table Global Rituximab Value ($) by Type (2015-2020)
Table Global Rituximab Value Share by Type (2015-2020)
Figure Global Rituximab Value Share by Type (2015-2020)
Table Global Rituximab Production by Type (2015-2020)
Table Global Rituximab Production Share by Type (2015-2020)
Figure Global Rituximab Production Share by Type (2015-2020)
Figure Global Rituximab Value ($) and Growth Rate of Solution (2015-2020)
Figure Global Rituximab Value ($) and Growth Rate of Injection (2015-2020)
Figure Global Rituximab Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Rituximab Consumption by Application (2015-2020)
Table Global Rituximab Consumption Market Share by Application (2015-2020)
Figure Global Rituximab Consumption Market Share by Application (2015-2020)
Figure Global Rituximab Consumption and Growth Rate of non-Hodgkin's lymphoma (NHL) (2015-2020)
Figure Global Rituximab Consumption and Growth Rate of chronic lymphocytic leukaemia (CLL) (2015-2020)
Figure Global Rituximab Consumption and Growth Rate of Others (2015-2020)
Figure Global Rituximab Sales and Growth Rate (2015-2020)
Figure Global Rituximab Revenue (M USD) and Growth (2015-2020)
Table Global Rituximab Sales by Regions (2015-2020)
Table Global Rituximab Sales Market Share by Regions (2015-2020)
Table Global Rituximab Revenue (M USD) by Regions (2015-2020)
Table Global Rituximab Revenue Market Share by Regions (2015-2020)
Table Global Rituximab Revenue Market Share by Regions in 2015
Table Global Rituximab Revenue Market Share by Regions in 2019
Figure North America Rituximab Sales and Growth Rate (2015-2020)
Figure Europe Rituximab Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Rituximab Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Rituximab Sales and Growth Rate (2015-2020)
Figure South America Rituximab Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Rituximab Revenue (M USD) and Growth (2015-2020)
Table North America Rituximab Sales by Countries (2015-2020)
Table North America Rituximab Sales Market Share by Countries (2015-2020)
Table North America Rituximab Revenue (M USD) by Countries (2015-2020)
Table North America Rituximab Revenue Market Share by Countries (2015-2020)
Figure United States Rituximab Sales and Growth Rate (2015-2020)
Figure Canada Rituximab Sales and Growth Rate (2015-2020)
Figure Mexico Rituximab Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Rituximab Revenue (M USD) and Growth (2015-2020)
Table Europe Rituximab Sales by Countries (2015-2020)
Table Europe Rituximab Sales Market Share by Countries (2015-2020)
Table Europe Rituximab Revenue (M USD) by Countries (2015-2020)
Table Europe Rituximab Revenue Market Share by Countries (2015-2020)
Figure Germany Rituximab Sales and Growth Rate (2015-2020)
Figure UK Rituximab Sales and Growth Rate (2015-2020)
Figure France Rituximab Sales and Growth (2015-2020)
Figure Italy Rituximab Sales and Growth (2015-2020)
Figure Spain Rituximab Sales and Growth (2015-2020)
Figure Russia Rituximab Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Rituximab Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Rituximab Sales by Countries (2015-2020)
Table Asia Pacific Rituximab Sales Market Share by Countries (2015-2020)
Table Asia Pacific Rituximab Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Rituximab Revenue Market Share by Countries (2015-2020)
Figure China Rituximab Sales and Growth Rate (2015-2020)
Figure Japan Rituximab Sales and Growth Rate (2015-2020)
Figure South Korea Rituximab Sales and Growth (2015-2020)
Figure India Rituximab Sales and Growth (2015-2020)
Figure Southeast Asia Rituximab Sales and Growth (2015-2020)
Figure Australia Rituximab Sales and Growth (2015-2020)
Figure Middle East Rituximab Revenue (M USD) and Growth (2015-2020)
Table Middle East Rituximab Sales by Countries (2015-2020)
Table Middle East and Africa Rituximab Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Rituximab Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Rituximab Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Rituximab Sales and Growth Rate (2015-2020)
Figure UAE Rituximab Sales and Growth Rate (2015-2020)
Figure Egypt Rituximab Sales and Growth (2015-2020)
Figure Nigeria Rituximab Sales and Growth (2015-2020)
Figure South Africa Rituximab Sales and Growth (2015-2020)
Figure South America Rituximab Revenue (M USD) and Growth (2015-2020)
Table South America Rituximab Sales by Countries (2015-2020)
Table South America Rituximab Sales Market Share by Countries (2015-2020)
Table South America Rituximab Revenue (M USD) by Countries (2015-2020)
Table South America Rituximab Revenue Market Share by Countries (2015-2020)
Figure Brazil Rituximab Sales and Growth Rate (2015-2020)
Figure Argentina Rituximab Sales and Growth Rate (2015-2020)
Figure Columbia Rituximab Sales and Growth (2015-2020)
Figure Chile Rituximab Sales and Growth (2015-2020)
Figure Top 3 Market Share of Rituximab Companies in 2019
Figure Top 6 Market Share of Rituximab Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Chugai Profile
Table Chugai Product Introduction
Figure Chugai Production and Growth Rate
Figure Chugai Value ($) Market Share 2015-2020
Table Genentech, Inc Profile
Table Genentech, Inc Product Introduction
Figure Genentech, Inc Production and Growth Rate
Figure Genentech, Inc Value ($) Market Share 2015-2020
Table Zenyaku Kogyo Profile
Table Zenyaku Kogyo Product Introduction
Figure Zenyaku Kogyo Production and Growth Rate
Figure Zenyaku Kogyo Value ($) Market Share 2015-2020
Table Biogen Profile
Table Biogen Product Introduction
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2015-2020
Table Roche Profile
Table Roche Product Introduction
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2015-2020
Table Market Driving Factors of Rituximab
Table Merger, Acquisition and New Investment
Table Global Rituximab Market Value ($) Forecast, by Type
Table Global Rituximab Market Volume Forecast, by Type
Figure Global Rituximab Market Value ($) and Growth Rate Forecast of Solution (2020-2025)
Figure Global Rituximab Market Volume ($) and Growth Rate Forecast of Solution (2020-2025)
Figure Global Rituximab Market Value ($) and Growth Rate Forecast of Injection (2020-2025)
Figure Global Rituximab Market Volume ($) and Growth Rate Forecast of Injection (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of non-Hodgkin's lymphoma (NHL) (2020-2025)
Figure Market Volume and Growth Rate Forecast of non-Hodgkin's lymphoma (NHL) (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of chronic lymphocytic leukaemia (CLL) (2020-2025)
Figure Market Volume and Growth Rate Forecast of chronic lymphocytic leukaemia (CLL) (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Rituximab Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
The Global Rituximab Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Global Rituximab Market across the extensive corporate landscape.
The majority of data for the Global Rituximab Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
